Generics News

Generics News

Par Launches Generic Megace ES

Par Pharmaceuticals announced the launch of Megestrol Acetate Suspension, the generic version of its brand Megace ES.

Breckenridge Launches Generic Astelin

Breckenridge announced the launch of Azelastine HCl Nasal Solution, the generic version of Meda's Astelin.

TWi Launches Generic Megace ES

TWi Pharmaceuticals announced the launch of Megestrol Acetate Suspension, the generic version of Par Pharmaceutical's Megace ES.

Fresenius Kabi Launches Glucagon for Injection

Fresenius Kabi announced the launch of Glucagon for Injection, which is indicated for use as a diagnostic aid during radiologic examinations.

ANI, Sofgen Approved for Nimodipine Capsules

ANI Pharmaceuticals and Sofgen announced that the Food and Drug Administration (FDA) has approved Nimodipine Capsules.

Amneal Expands Generic Line With 4 New Products

Amneal announced the recent launch of four new products: Tobramycin Inhalation Solution, Memantine HCl Immediate Release Tablets, Temozolomide Capsules, and Divalproex Sodium Extended Release Tablets.

Hospira Launches Generic Angiomax

Hospira announced the launch of Bivalirudin for Injection, the first generic version of The Medicines Company's Angiomax.

Mylan Launches Generic Namenda

Mylan announced the launch of Memantine HCl Tablets, the generic version of Actavis' Namenda.

Dr. Reddy's Launches Generic Namenda

Dr. Reddy's Laboratories announced the launch of Memantine HCI Tablets, the generic version of Actavis' Namenda.

IGI Labs Launch Diclofenac Sodium 1.5% Topical Solution

IGI Laboratories announced the launch of Diclofenac Sodium 1.5% Topical Solution, following the final approval from the Food and Drug Administration (FDA).